Early Access — free while we kick the tires
EdgarHawk

SAFX XCF Global, Inc. Insider Trading

Latest: Insider Sold $3.1M of Shares · Apr 2026
2 filings analyzed · Latest 2026-05-22
Insider buys
0
Insider sells
2
Unique insiders
1
Direction
Net selling
May 2026
2026-05-22
medium
Randy Soule Sell
5,000,000 shares
$2,037,000
@ $0.41
Significance 3/10

10% owner Randy Soule sold 5,000,000 shares of SAFX at $0.41 on 2026-05-15 for $2,037,000.00, reducing stake to 72,383,239 shares.

Randy Soule, a 10% owner, divested 5.00M shares (down 6.5% from prior holdings) at $0.41 per share on May 15, 2026. The company fundamentals show severe distress: latest quarterly revenue of $348,688.00 against net income of $-17,812,415.00. Soule's prior open-market sell on 2026-04-30 at this same ticker returned +27.5% over 90 days, indicating the stock rose after that sale—a poorly-timed exit. The current sale follows just 15 days later, suggesting ongoing portfolio activity amid negative earnings momentum rather than a singular conviction-driven transaction. The persistence of open-market sells while the company reports substantial losses warrants attention to underlying liquidity pressures and insider confidence signals.

2026-05-08
low
Randy Soule Sell
9,000,000 shares
$3,096,000
@ $0.34
Significance 3/10

10% owner Randy Soule sells 9M shares; stock deep underwater from all-time highs despite recent rally.

Randy Soule, a ten-percent beneficial owner of XCF Global, sold roughly 12% of his holdings in a single transaction. The stock is trading dramatically below its all-time highs despite a significant gain over the past three months, and the company remains profitable with solid recent earnings. Soule's sale follows 17 prior open-market sales and no prior open-market purchases on his Form 4 record, establishing a persistent pattern of share dispositions. The timing of this sale—after a sharp recent rally but while the stock remains severely depressed versus its annual highs—is notable: many investors sell into strength after sharp gains, which may explain the transaction's placement in the recent price recovery. Without additional context on Soule's broader portfolio or reasons for the sale, the disposition appears routine for an institutional-scale holder managing a large position.

More Chemicals and Allied Products companies

Get alerts for SAFX

Add SAFX to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access